Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sativex for uncontrolled persistent chronic pain in advanced cancer
NCT01424566Phase 3Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Jun 2012
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of cannabis extract in cancer pain, sponsored by Jazz Pharmaceuticals plc. Started Jun 2012; status: completed.
02
Drugs
cannabis extract
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT01424566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01424566.